Skip to main content
Log in

Synthesis, antiproliferative activity, and molecular docking studies of curcumin analogues bearing pyrazole ring

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Several curcumin analogues bearing pyrazole were synthesized and characterized by IR, NMR, and mass spectral data. There were four tested compounds among 11 synthesized compounds, which were evaluated for antiproliferative activity and showed significant activity in both one-dose and five-dose assays. The antiproliferative effects were tested on a panel of 60 cell lines, according to the National Cancer Institute screening protocol. The most active compounds among the series were 3,5-bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-carboxamide (3k) which showed mean percent growth inhibition of 116.09 in one-dose assay at 10 µM, and GI50 values were ranging between 0.0912 and 2.36 µM in five-dose assay. The best results were recorded on the leukaemia cell lines with value ranging from 0.0912 to 0.365 µM. All the tested compounds showed broad-spectrum antiproliferative activity over different cancer cell lines. When compared with the standard drug paclitaxel, the compound 3k showed superior activity on nearly 42 cell lines. The molecular docking study was performed to explore the binding interaction of these curcumin analogues with the active site of EGFR tyrosine kinase (EGFR-TK). The hydroxyl group of both phenyl rings was important for the rein-geminated hydrogen bonding by either side chain or backbone with the active site of EGFR-TK.

Graphical Abstract

Four curcumin analogues were evaluated for their antiproliferative activity and showed promising results. The molecular docking studies showed that all the compounds (3ak) were well accommodated in the EGFR tyrosine kinase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  • Ahsan MJ, Khalilullah H, Yasmin S, Jadav SS, Govindasamy J (2013) Synthesis, characterisation, and in vitro anticancer activity of curcumin analogues bearing pyrazole/pyrimidine ring targeting EGFR tyrosine kinase. Bio Med Res Int 2013:239354. doi:10.1155/2013/239354

    Google Scholar 

  • Alley MC, Scudiero DA, Monks PA, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589–601

    CAS  PubMed  Google Scholar 

  • Aydemir N, Bilaloglu R (2003) Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo. Mutat Res 537:43–51

    Article  CAS  PubMed  Google Scholar 

  • Balaji SN, Ahsan MJ, Jadav SS, Trivedi V (2015) Molecular modeling, synthesis and antimalarial potentials of curcumin analogues containing heterocyclic ring. Arab J Chem. doi:10.1016/j.arabjc.2015.04.011

    Google Scholar 

  • Blair JA, Rauh D, Kung C, Yun CH, Fan Q, Rode H, Zhang C, Eck MJ, Weiss WA, Shokat KM (2007) Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nat Chem Bio 4:229–238

    Article  Google Scholar 

  • Boyd MR, Paull KD (1995) Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res 34:91–109

    Article  CAS  Google Scholar 

  • Carmona D, Saez J, Granados H, Perez E, Blair S, Angulo A, Figadere B (2003) Antiprotozoal 6-substituted-5,6-dihydro-alpha-pyrones from Raimondia cf. monoica. Nat Prod Res 17:275–280

    Article  CAS  PubMed  Google Scholar 

  • Cragg GM, Newman DJ (2005) Biodiversity: a continuing source of novel drug leads. Pure Appl Chem 77:7–24

    CAS  Google Scholar 

  • Development therapeutic program NCI/NIH (2014). http://dtp.nci.nih.gov. Accessed 13 Nov 2014

  • Grever MR, Schepartz SA, Chabner BA (1992) The National Cancer Institute: cancer drug discovery and development program. Semin Oncol 19:622–638

    CAS  PubMed  Google Scholar 

  • Jia Y, Li J, Qin ZH, Liang ZQ (2009) Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. J Asian Nat Prod Res 11:918–928

    Article  CAS  PubMed  Google Scholar 

  • Koepfli JB, Mead JF, Brockman JA (1947) An alkaloid with high antimalarial activity from Dichroa Febrifuga1. J Am Chem Soc 69:1837

    Article  CAS  PubMed  Google Scholar 

  • Kunwar A, Barik A, Mishra B, Rathinasamy K, Pandey R, Priyadarsini K (2008) Phytochemicals as modulators of neoplastic phenotypes. Biochem Biophy Act 1780:673–679

    Article  CAS  Google Scholar 

  • Lal J, Gupta SK, Thavaselvam D, Agrawal DD (2012) Design, synthesis, synergistic antimicrobial activity and cytotoxicity of 4-aryl substituted 3,4-dihydropyrimidinones of curcumin. Bioorg Med Chem 22:2872–2876

    Article  CAS  Google Scholar 

  • Liang G, Shao L, Wang Y, Zhao C, Chu Y, Xiao J, Zhao Y, Li X, Yang S (2009) Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents. Bioorg Med Chem 17:2623–2631

    Article  CAS  PubMed  Google Scholar 

  • Mendelsohn J, Baselga J (2000) The EGF receptor family as targets for cancer therapy. Oncogene 19:6550–6565

    Article  CAS  PubMed  Google Scholar 

  • Mishra S, Karmodiya K, Surolia N, Surolia A (2008) Synthesis and exploration of novel curcumin analogues as anti-malarial agents. Bioorg Med Chem 16:2894–2902

    Article  CAS  PubMed  Google Scholar 

  • Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Gray-Goodrich M, Campbell H, Mayo J, Boyd M (1991) Feasibility of a high-flux anticancer drug screening using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83:757–766

    Article  CAS  PubMed  Google Scholar 

  • NCI Data Warehouse Index (2014). http://dtp.nci.nih.gov/dtpstandard/dwindex/index.jsp. Accessed 13 Nov 2014

  • Normanda N, Maiello MR, Luca AD (2002) Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): Simple drugs with a complex mechanism of action? J Cell Physiol 194:13–19

    Article  Google Scholar 

  • Pari L, Tewas D, Eckel J (2008) Role of curcumin in health and disease. Arch Physiol Biochem 114:127–149

    Article  CAS  PubMed  Google Scholar 

  • Sahu PK, Sahu PK, Gupta SK, Thavaselvam D, Agarwal DD (2012) Synthesis and evaluation of antimicrobial activity of 4H-pyrimido[2,1-b]benzothiazole, pyrazole and benzylidene derivatives of curcumin. Eur J Med Chem 54:366–378

    Article  CAS  PubMed  Google Scholar 

  • Saja K, Babu MS, Karunagaran D, Sudhakaran PR (2007) Anti-inflammatory effect of curcumin involves down regulation of MMP-9 in blood mononuclear cells. Int Immunopharm 7:1659–1667

    Article  CAS  Google Scholar 

  • Sharma R, Jadav SS, Yasmin S, Bhatia S, Khalilullah H, Ahsan MJ (2015) Simple efficient and improved synthesis of Biginelli-type compounds of curcumin as anticancer agents. Med Chem Res 24:236–244

    Google Scholar 

  • Shoemaker RH (2006) The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6:813–823

    Article  CAS  PubMed  Google Scholar 

  • Singh RK, Rai D, Yadav D, Bhargava A, Balzarini J, DeClercq E (2010) Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid. Eur J Med Chem 45:1078–1086

    Article  CAS  PubMed  Google Scholar 

  • Vyas A, Dandawate P, Padhye S, Ahmad A, Sarkar F (2013) Perspectives on new synthetic curcumin analogs and their potential anticancer properties. Curr Pharm Des 19:2047–2069

    PubMed Central  CAS  PubMed  Google Scholar 

  • WHO World Cancer Report 2014. Retrieved from http://www.nydailynews.com/life-style/health/14-million-people-cancer-2012-article-1.1545738. Retrieved on 12 Dec 2013

  • Yadav IS, Nandekar PP, Shrivastava S, Sangamwar A, Chaudhury A, Agarwal SM (2014) Ensemble docking and molecular dynamics identify knoevenagel curcumin derivatives with potent anti-EGFR activity. Gene 539:82–90

    Article  CAS  PubMed  Google Scholar 

  • Yar MS, Siddiqui AA, Ali A (2007) Synthesis and anti tuberculostatic activity of novel 1,3,4-oxadiazole derivatives. J Chin Chem Soc 54:5–8

    Article  CAS  Google Scholar 

  • Zhichang L, Yinghong W, Yuanqin Z, Qinxiang X (2012) Synthesis and antibacterial activities of N-substituted pyrazole curcumin derivatives. Chin J Org Chem 32:1487–1492

    Article  Google Scholar 

Download references

Acknowledgments

Antiproliferative data were provided by National Cancer Institute (NCI US), Bethesda, MD, USA. We are grateful for all help provided by Prof. Doug Smallwood and Mr. Mohammed Nayel. The people holding the management of Maharishi Arvind College of Pharmacy, Jaipur, Rajasthan, India, are acknowledged for providing research facilities. We are also grateful to Dr. Reddy Institute of Life Science, Hyderabad, Andhra Pradesh, India, for providing spectral data of synthesized compounds.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Mohamed Jawed Ahsan or Kavita Choudhary.

Ethics declarations

Conflict of interest

The authors confirm that this article content has no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahsan, M.J., Choudhary, K., Jadav, S.S. et al. Synthesis, antiproliferative activity, and molecular docking studies of curcumin analogues bearing pyrazole ring. Med Chem Res 24, 4166–4180 (2015). https://doi.org/10.1007/s00044-015-1457-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-015-1457-y

Keywords

Navigation